References
French MA (2009) Immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 48(1):101–107
Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60(12):1978–1980
Kuntzer T, Carota A, Novy J, Cavassini M, Du Pasquier RA (2011) Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis. Neurology 76(8):757–758. doi:10.1212/WNL.0b013e31820d6290
Kurokawa T, Nishiyama T, Yamamoto R, Kishida H, Hakii Y, Kuroiwa Y (2008) Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report. Rinsho Shinkeigaku 48:666–669
Knopf L, Menkes DL (2010) Comorbid HIV and myasthenia gravis: case report and review of the literature. J Clin Neuromuscul Dis 12(2):80–84
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical standard
The patient consented to the treatment in the hospital. This is a case study and hence no ethical approval was obtained from the hospital ethics committee.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ragunathan, K., Pathak, B. & Dahal, K. MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. J Neurol 262, 777–778 (2015). https://doi.org/10.1007/s00415-015-7639-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7639-1